Vertaling van "whether and " (Frans → Nederlands) :

Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.
This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.

“AD caregivers are typically the first to notice when their loved one’s symptoms are becoming worse and whether the disease may be progressing to the next stage, which is why caregivers are essential partners in disease management discussions,” said Barry W. Rovner, M.D., director of the Division of Geriatric Psychiatry and professor in the departments of Neurology and Psychiatry at Thomas Jefferson University , Philadelphia .
“AD caregivers are typically the first to notice when their loved one’s symptoms are becoming worse and whether the disease may be progressing to the next stage, which is why caregivers are essential partners in disease management discussions,” said Barry W. Rovner, M.D., director of the Division of Geriatric Psychiatry and professor in the departments of Neurology and Psychiatry at Thomas Jefferson University, Philadelphia.

Assess whether funding is allocated efficiently, taking into account societal benefits, including those generated by promotion, prevention and care.
Assess whether funding is allocated efficiently, taking into account societal benefits, including those generated by promotion, prevention and care. iv. Evaluate whether coverage is comprehensive and fair in social and private insurancebased systems, on an equal level to that for other conditions, not excluding or discriminating against groups and particularly protecting the most vulnerable.

The purpose of this study was to determine whether the use of cushione [ publication ] [ 1/03/2012 ]
The purpose of this study was to determine whether the use of cushione [ publicatie ] [ 1/03/2012 ]

Development of a reliable method to assess footwear comfort during running The purposes of this study were: (a) to determine whether subjects are able to distinguish between differences in footwear with respect to footwear comfort; and (b) to determine how reliably footwear comfort can be assessed using a visual analogue sc [ publication ] [ 1/03/2012 ]
Development of a reliable method to assess footwear comfort during running The purposes of this study were: (a) to determine whether subjects are able to distinguish between differences in footwear with respect to footwear comfort; and (b) to determine how reliably footwear comfort can be assessed using a visual analogue sc [ publicatie ] [ 1/03/2012 ]

Indeed, since the end of the 20th the medical workforce was estimated by the total number of licensed century, a strong de-institutionalization movement in the mental healthcare medical doctors (regardless of whether they worked in the healthcare sector has led to the development of new models of organization.
Indeed, since the end of the 20th medical doctors (regardless of whether they worked in the healthcare century, a strong de-institutionalization movement in the mental healthcare sector or not).

It depends on the content of the questions a person has to answer and the perspective he/she (has to) adopt(s) when answering the questions whether he acts as a citizen or a patient.
Being a ‘citizen’ or a ‘patient’ is not a status, but rather a role one adopts in a specific context. It depends on the content of the questions a person has to answer and the perspective he/she (has to) adopt(s) when answering the questions whether he acts as a citizen or a patient.